Earlier studies have shown that many CSF innate immune activation markers in AD are associated with tau‐pathology,17, 18 highlighting the latter as a promising candidate for exploring interactions between immune‐related genetic risk and core pathologies in the AD continuum. Here, MAPT is linked to Alzheimer disease.